An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

NCT07644832 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A
Hemophilia B
Factor VII Deficiency

Interventions

DRUG: SR604
DRUG: SR604
DRUG: SR604

Sponsor

Shanghai RAAS Blood Products Co., Ltd.